Chlordiazepoxide / Methscopolamine Side Effects
Applies to chlordiazepoxide/methscopolamine: oral capsule.
Dermatologic adverse events
Dermatologic side effects have rarely included skin eruptions.[Ref]
Gastrointestinal
Gastrointestinal side effects have included nausea, constipation, and dryness of the mouth.[Ref]
Genitourinary
Genitourinary side effects have included minor menstrual irregularities and urinary hesitancy.[Ref]
Hematologic
Hematologic side effects have included blood dyscrasias, including agranulocytosis.[Ref]
Hepatic
Hepatic side effects have rarely included jaundice and hepatic dysfunction.[Ref]
Periodic blood counts and liver function tests are recommended when chlordiazepoxide treatment is prolonged.[Ref]
Ocular
Ocular side effects have included blurring of vision.[Ref]
Nervous system
Nervous system side effects have included drowsiness and confusion. Changes in EEG patterns (low-voltage fast activity) has also been reported during and after chlordiazepoxide treatment. Rarely, syncope has been reported.[Ref]
The elderly and debilitated may be more susceptible to the side effects of chlordiazepoxide. Drowsiness, ataxia, and confusion have occasionally been reported at the lower dosage ranges.[Ref]
Other
Other side effects have rarely included reports of increased and decreased libido.[Ref]
Edema has been reported during chlordiazepoxide therapy.[Ref]
References
1. (2004) "Product Information. Librax (chlordiazepoxide-methscopolamine)." Victory Pharma
More about chlordiazepoxide / methscopolamine
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: anticholinergics/antispasmodics
Related treatment guides
Further information
Chlordiazepoxide/methscopolamine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.